Hawkes D (2017) Response to “vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial”. Clin Rheumatol. doi:10.1007/s10067-017-3609-6
PubMed
Google Scholar
Martinez-Lavin M (2017) Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial. Clin Rheumatol. doi:10.1007/s10067-017-3575-z
Google Scholar
European Medicines Agency Assessment Report Review under Article 20 of Regulation (EC) No 726/2004 Human papillomavirus (HPV) vaccines http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/HPV_vaccines_20/Opinion_provided_by_Committee_for_Medicinal_Products_for_Human_Use/WC500197129.pdf Accessed March 29, 2017.
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A, Broad Spectrum HPVVS (2015) A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 372(8):711–723. doi:10.1056/NEJMoa1405044
CAS
Article
PubMed
Google Scholar
Martínez-Lavín M, Martínez-Martínez L-A, Reyes-Loyola P (2015) HPV vaccination syndrome. A questionnaire-based study Clin Rheumatol 34:1981–1983
Article
PubMed
Google Scholar
Brinth L, Theibel AC, Pors K, Mehlsen J (2015) Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J 62:A5064
PubMed
Google Scholar
Chandler RE, Juhlin K, Fransson J, Caster O, Edwards IR, Norén GN (2017) Current safety concerns with human papillomavirus vaccine: a cluster analysis of reports in VigiBase. Drug Saf. doi:10.1007/s40264-016-0456-3
Google Scholar